17 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
of any use, generation, manufacture, storage, disposal, release or threatened release of a hazardous waste or substance on the Collateral … such investigations, studies, samplings and testings as may be requested by the Lender or any governmental authority relative to any substance, or any waste
424B3
0guj8q
14 Aug 23
Prospectus supplement
4:30pm
S-4/A
xbdfdqdhsyhn bv2isg3
26 Jun 23
Registration of securities issued in business combination transactions (amended)
5:02pm
S-4
j06q2
15 May 23
Registration of securities issued in business combination transactions
3:02pm
425
EX-2.1
6c75rxslzhj2t49
17 Apr 23
Business combination disclosure
6:02am
8-K
EX-2.1
ljs8cz02p1w qxdalt
17 Apr 23
Entry into a Material Definitive Agreement
6:01am
- Prev
- 1
- Next